356 related articles for article (PubMed ID: 15050913)
21. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.
Wong CM; Fan ST; Ng IO
Cancer; 2001 Jul; 92(1):136-45. PubMed ID: 11443619
[TBL] [Abstract][Full Text] [Related]
22. beta-catenin mutations are absent in hepatocellular carcinomas of SV40 T-antigen transgenic mice.
Umeda T; Yamamoto T; Kajino K; Hino O
Int J Oncol; 2000 Jun; 16(6):1133-6. PubMed ID: 10811985
[TBL] [Abstract][Full Text] [Related]
23. Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation.
Gross-Goupil M; Riou P; Emile JF; Saffroy R; Azoulay D; Lacherade I; Receveur A; Piatier-Tonneau D; Castaing D; Debuire B; Lemoine A
Int J Cancer; 2003 May; 104(6):745-51. PubMed ID: 12640682
[TBL] [Abstract][Full Text] [Related]
24. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J
Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629
[TBL] [Abstract][Full Text] [Related]
25. Mutation and overexpression of the beta-catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people.
Cui J; Zhou X; Liu Y; Tang Z
J Cancer Res Clin Oncol; 2001 Sep; 127(9):577-81. PubMed ID: 11570580
[TBL] [Abstract][Full Text] [Related]
26. PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma.
Pang R; Yuen J; Yuen MF; Lai CL; Lee TK; Man K; Poon RT; Fan ST; Wong CM; Ng IO; Kwong YL; Tse E
Oncogene; 2004 May; 23(23):4182-6. PubMed ID: 15064734
[TBL] [Abstract][Full Text] [Related]
27. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
28. Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma.
Merle P; de la Monte S; Kim M; Herrmann M; Tanaka S; Von Dem Bussche A; Kew MC; Trepo C; Wands JR
Gastroenterology; 2004 Oct; 127(4):1110-22. PubMed ID: 15480989
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of E-cadherin and I-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-alpha.
Masuda T; Saito H; Kaneko F; Atsukawa K; Morita M; Inagaki H; Kumagai N; Tsuchimoto K; Ishii AH
In Vitro Cell Dev Biol Anim; 2000 Jun; 36(6):387-94. PubMed ID: 10949998
[TBL] [Abstract][Full Text] [Related]
30. Truncated form of beta-catenin and reduced expression of wild-type catenins feature HepG2 human liver cancer cells.
Carruba G; Cervello M; Miceli MD; Farruggio R; Notarbartolo M; Virruso L; Giannitrapani L; Gambino R; Montalto G; Castagnetta L
Ann N Y Acad Sci; 1999; 886():212-6. PubMed ID: 10667222
[No Abstract] [Full Text] [Related]
31. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin.
Asayama Y; Taguchi Ki K; Aishima Si S; Nishi H; Masuda K; Tsuneyoshi M
Liver; 2002 Feb; 22(1):43-50. PubMed ID: 11906618
[TBL] [Abstract][Full Text] [Related]
32. P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells.
Cagatay T; Ozturk M
Oncogene; 2002 Nov; 21(52):7971-80. PubMed ID: 12439747
[TBL] [Abstract][Full Text] [Related]
33. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K
Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
Chen Ban K; Singh H; Krishnan R; Fong Seow H
J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
[TBL] [Abstract][Full Text] [Related]
35. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma.
Branda M; Wands JR
Hepatology; 2006 May; 43(5):891-902. PubMed ID: 16628664
[No Abstract] [Full Text] [Related]
36. Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.
Calvisi DF; Factor VM; Ladu S; Conner EA; Thorgeirsson SS
Gastroenterology; 2004 May; 126(5):1374-86. PubMed ID: 15131798
[TBL] [Abstract][Full Text] [Related]
37. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.
de La Coste A; Romagnolo B; Billuart P; Renard CA; Buendia MA; Soubrane O; Fabre M; Chelly J; Beldjord C; Kahn A; Perret C
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8847-51. PubMed ID: 9671767
[TBL] [Abstract][Full Text] [Related]
38. [Molecular mechanism of hepatocarcinogenesis].
Imazeki F; Saisho H
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2154-61. PubMed ID: 10635298
[TBL] [Abstract][Full Text] [Related]
39. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.
Ding Q; Xia W; Liu JC; Yang JY; Lee DF; Xia J; Bartholomeusz G; Li Y; Pan Y; Li Z; Bargou RC; Qin J; Lai CC; Tsai FJ; Tsai CH; Hung MC
Mol Cell; 2005 Jul; 19(2):159-70. PubMed ID: 16039586
[TBL] [Abstract][Full Text] [Related]
40. Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas.
Terris B; Pineau P; Bregeaud L; Valla D; Belghiti J; Tiollais P; Degott C; Dejean A
Oncogene; 1999 Nov; 18(47):6583-8. PubMed ID: 10597262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
